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Background: The role of transesophageal echocardiography (TEE) in the evaluation of acute 
stroke patients is still ill-deﬁ  ned. We conducted a prospective observational study to ﬁ  nd the 
prevalence of TEE ﬁ  ndings that indicate anticoagulation as beneﬁ  cial, in acute ischemic stroke 
patients without indication for anticoagulation based on clinical, electrocardiographic and 
transthoracic echocardiography (TTE) ﬁ  ndings.
Methods: We prospectively studied all patients referred to our laboratory for TTE and TEE. 
Patients were excluded if the diagnosis was not acute ischemic stroke or if they had an indica-
tion for anticoagulation based on clinical, electrocardiographic, or TTE data. Patients with TEE 
ﬁ  ndings that might indicate anticoagulation as beneﬁ  cial were identiﬁ  ed.
Results: A total of 84 patients with acute ischemic stroke and without indication for antico-
agulation based on clinical and electrocardiographic or TTE data were included in the study. 
Findings indicating anticoagulation as beneﬁ  cial were found in 32.1%: spontaneous echo contrast 
(1.2%), complex aortic atheroma (27.4%), thrombus (8.3%), and simultaneous patent foramen 
ovale and atrial septal aneurysm (2.4%).
Conclusions: The results of our study show that TEE can have therapy implications in 
32.1% of ischemic stroke patients in sinus rhythm and with TTE with no indication for 
anticoagulation.
Keywords: acute ischemic stroke, transesophageal echocardiography, transthoracic 
echocardiography, therapy
Introduction
The role of transesophageal echocardiography (TEE) in the evaluation of acute stroke 
patients is still ill-deﬁ  ned (Adams et al 2003; Hack et al 2003).
While some studies conclude that TEE should be mandatory on all ischemic stroke 
patients, based on its cost-effectiveness (McNamara et al 1997) and sensitivity for 
ﬁ  ndings that change clinical management (coumadin instead of aspirin) (Blum et al 
2004), others ﬁ  nd that TEE abnormalities are found mostly in patients already with 
clinical, electrocardiographic or transthoracic echocardiography (TTE) data that 
would justify anticoagulation, and are rare in patients with sinus rhythm and with a 
normal TTE (Leung et al 1995; Cabral et al 2001; Agmom and Khandheria 2002). 
As a consequence, the usefulness of TEE ﬁ  ndings for the clinical management of 
ischemic stroke patients has been challenged, but not deﬁ  ned, with some authors 
defending TEE only on patients with abnormal TTE (Leung et al 1995), with a nor-
mal TTE (Nighoghossian 1995), on an individual patient basis (Cabral et al 2001), or 
questioning its usefulness in the management of any ischemic stroke patient (Warner 
and Momah 1996).Vascular Health and Risk Management 2008:4(1) 168
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The aim of our study was to ﬁ  nd the prevalence of TEE 
ﬁ  ndings that indicate anticoagulation as beneﬁ  cial, in acute 
ischemic stroke patients without indication for anticoagulation 
based on clinical, electrocardiographic, and TTE ﬁ  ndings.
Methods
This was a prospective observational study, carried out from 
April 13, 2004 to October 11, 2005. The study was approved 
by our hospital ethics committee. Informed consent was 
obtained from all patients.
Patients
All patients referred to our laboratory simultaneously for TEE 
and TTE were enrolled in the study. Patients were excluded 
if the diagnosis was not acute ischemic stroke, or if they 
had an indication for anticoagulation based on clinical and 
electrocardiographic or TTE data.
The diagnosis of stroke was made by the referring physi-
cians, based on clinical data and brain CT.
Echography
All the echographic studies were performed by the authors, 
on a Vivid 3 System, General Electric.
Transthoracic echocardiography was performed using a 
2.5-MHz transducer for M-mode, 2D, and Doppler, according 
to the recommendations of the American Echocardiography 
Society (Henry et al 1980).
Transesophageal echocardiography was performed using 
a multiplane 3.5 to 6.5 MHz probe, according to standard 
protocols (Seward et al 1988). The presence of the following 
potential sources of embolism was speciﬁ  cally examined: 
(a) left atrial spontaneous echo contrast and thrombus; (b) 
atheroma in the thoracic aorta; (c) patent foramen ovale and 
atrial septal aneurysm; and (d) others, including valvular 
vegetations and intracardiac masses. Left atrial spontaneous 
echo contrast was diagnosed by the presence of characteristic 
dynamic smokelike swirling echo in the left atrium or the 
atrial appendage, distinct from background white noise due 
to excessive gain (Black et al 1991). Left atrial thrombus 
was diagnosed by the presence of an echodense mass in 
the left atrium or the left atrial appendage, distinct from 
the endocardium and the pectinate muscles of the left atrial 
appendage (Beppu et al 1984). The presence of atheroma in 
the thoracic aorta was examined. Atheroma that were mobile, 
pedunculated, or protruding  5 mm into the lumen were 
classiﬁ  ed as complex atheroma (Karalis et al 1985; Katz 
et al 1992). All other sessile atheroma  5 mm in thickness 
were classiﬁ  ed as simple atheroma. The interatrial septum 
was examined for patent foramen ovale, atrial septal defect, 
and atrial septal aneurysm. Color doppler, without and with 
Valsalva manoeuvre, and bubble contrast study with agitated 
saline, also without and with Valsalva manoeuvre, were 
performed in all patients to look for interatrial shunting. 
Bubbles appearing in the left atrium within three cardiac 
cycles or observed traversing the interatrial septum consti-
tuted a positive study for shunting. Atrial septal aneurysm 
was deﬁ  ned as a thin-walled area in the region of the fossa 
ovalis with a base of at least 1.5 cm and an excursion with 
the cardiac cycle of at least 1.5 cm (Hanley et al 1985). Care 
was taken to distinguish a true atrial septal aneurysm from a 
hypermobile interatrial septum.
Indications for anticoagulation
TTE ﬁ  ndings that were considered to indicate anticoagulation 
as beneﬁ  cial (Tribolet de Abreu et al 2005) were deﬁ  ned as: 
mitral valve stenosis with an enlarged ( 55 mm) left atria, 
valve prosthesis, left ventricular systolic dysfunction (with 
an estimated ejection fraction  35%), dilated cardiopathy, 
previous myocardial infarction (with left ventricular wall 
dyskinesis), left atria or left ventricle masses.
TEE ﬁ  ndings that were considered to indicate anticoagu-
lation as beneﬁ  cial were deﬁ  ned as: left atrial spontaneous 
echo contrast and thrombus (Blum et al 2004), complex 
aortic atheroma (Amarenco et al 1994; Jones et al 1995), 
simultaneous patent foramen ovale and atrial septal aneurysm 
(Mas et al 2001; Kizer et al 2005), thrombus on any heart 
chamber, valve, or the aorta.
Statistical analysis
The program Statistical Package for the Social Sciences ver-
sion 12.0 for Windows was used as a database.
Results
During the study period, 143 patients were sent to our labo-
ratory for both TTE and TEE. In addition to 28 repeated 
examinations, a total of 31 patients were excluded for 
nonstroke diagnosis and for indications of anticoagulation 
before the performance of transesophageal echocardiography 
(Figure 1), leaving 84 patients included in the study.
The baseline characteristics and risk factors of the study 
patients are shown in Table 1.
A total of 27 (32.1%) patients had TEE ﬁ  ndings that might 
indicate anticoagulation as beneﬁ  cial (Table 2), three of which 
had more than one ﬁ  nding (left atrial spontaneous echo contrast 
and complex aortic atheroma [1 patient], thrombus in the aortic 
artery wall and complex aortic atheroma [2 patients]).Vascular Health and Risk Management 2008:4(1) 169
Therapeutic implications of transesophageal echocardiography
Table 3). Only one of them was prospective (Harloff 2006), 
three included patients without a previous TTE (Warner 
and Momah 1996; Palazzuoli 2000; Tatani 2001), and two 
included patients with atrial ﬁ  brilation (Warner and Momah 
1996; Harloff 2006). Only two of the studies speciﬁ  ed the 
number of patients who had simultaneous patent foramen 
ovale and atrial septal aneurysm (Tatani 2001; Harloff 2006). 
This fact is relevant, since anticoagulation is considered ben-
eﬁ  cial only in patients with both these abnormalities (Mas 
et al 2001; Kizer et al 2005).
The most recent of these studies, by Harloff and col-
leagues (2006), was a prospective study in which TEE was 
performed on 503 out of 564 consecutive ischemic stroke 
patients, including patients excluded from our study, such 
as patients already with indications for anticoagulation, 
as atrial ﬁ  brilation and other types of cardioembolic 
stroke, and patients with contraindications against oral 
anticoagulation. They found spontaneous echo contrast 
in 11.5%, complex aortic atheroma in 19.7%, thrombus 
in 7.2% and simultaneous patent foramen ovale and 
atrial septal aneurysm in 9%. They concluded that “TEE 
is indispensable in all patients being candidates for oral 
anticoagulation”.
Our study patients were a selected group who were 
referred for TEE by the attending physician. During our study, 
a total of 855 patients were admitted to our hospital with a 
Figure 1 Diagram of patient enrollment.
Of the 7 patients with thrombus, 4 had thrombus in the 
aortic valve leaﬂ  ets, and three patients had thrombus in the 
aortic artery wall.
Discussion
In our study, TEE had ﬁ  ndings that might indicate anticoagu-
lation as beneﬁ  cial in 32.1% of our population of ischemic 
stroke patients, without other indications for anticoagulation 
by clinical, electrocardiographic or TTE data.
We found seven similar published studies (Leung 
et al 1995; Warner and Momah 1996; Palazzuoli 2000; 
Cabral et al 2001; Tatani 2001; Ward 2006; Harloff 2006; 
Table 1 Baseline characteristics and risk factors of the study 
patients
Characteristic/risk factor  Study patients (n = 84)
Age, years (mean ± SD)  58 ± 13
Male sex  50 (60%)
Hypertension 57  (68%)
Present smoking  23 (27%)
Hypercholesterolemia 30  (36%)
Diabetes mellitus  17 (20%)
Table 2 Transesophageal echocardiography ﬁ  ndings indicating 
anticoagulation as beneﬁ  cial
Finding  Number of patients (%)
Left atrial spontaneous echo contrast  1 (1.2%)
Thrombus 7  (8.3%)
Atrial septal aneurism  10 (11.9%)
Patent foramen ovale  3 (3.6%)
Simultaneous patent foramen ovale  2 (2.4%)
and atrial septal aneurysm 
Complex aortic atheroma  23 (27.4%)
Total patients with TEE ﬁ  ndings indicating  27 (32.1%)
anticoagulation as beneﬁ  cial 
143 patients with
TTE and TEE
115 patients with 
TTE and TEE
28 patients had 
repeated
examinations
12 patients had 
non-stroke
diagnosis
103 stroke patients
with TTE and TEE
7 patients with 
atrial fibrilation
12 patients with TTE 
with indication for 
anticoagulation
84 patients in the 
studyVascular Health and Risk Management 2008:4(1) 170
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Figure 2 Proposed algorithm for the use of ultrasonographic studies on ischemic stroke patients.
ischemic stroke patients, for
whom chronic
anticoagulation is an option
electrocardiogram
atrial fibrilation sinus rhythm
anticoagulation transthoracic
echocardiography
findings indicating
anticoagulation as
beneficial
no findings indicating
anticoagulation as
beneficial
anticoagulation transesophageal
echocardiogram
findings indicating
anticoagulation as
beneficial
anticoagulation
no findings indicating
anticoagulation as
beneficial
antiplateletsVascular Health and Risk Management 2008:4(1) 171
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diagnosis of stroke (ischemic or hemorrhagic) or transient 
ischemic attack. Even if we consider 15% of these patients 
to have had an hemorrhagic stroke, the 143 patients in our 
study would represent approximately 20% of the remaining 
727 patients. We cannot compensate for this bias.
Several TEE ﬁ  ndings that might indicate anticoagulation 
as beneﬁ  cial for secondary prophylaxis in ischemic stroke 
patients have been identiﬁ  ed (Amarenco et al 1994; Jones 
et al 1995; Mas et al 2001; Blum et al 2004; Kizer et al 
2005). The superiority of TEE over TTE for diagnosing 
these abnormalities has also been demonstrated (McNamara 
et al 1997; Blum et al 2004), and conﬁ  rmed in our study. 
The prevalence of these abnormalities in a large unselected 
population of consecutive ischemic stroke patients has 
recently been studied by Harloff and colleagues (2006). 
Our results seem to conﬁ  rm their ﬁ  ndings, but on a more 
selected population of patients with no other indication for 
anticoagulation. Based on our study and on the study by Har-
loff and colleagues, we propose an algorithm for the use of 
ultrasonographic studies on ischemic stroke patients without 
contraindications for long term anticoagulation (Figure 2).
The results of our study show that TEE can have therapy 
implications in 32.1% of ischemic stroke patients in sinus 
rhythm and with a previous TTE with no indication for 
anticoagulation.
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